Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    8068936 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Genome Expression in Lymphoma, Leukemia and Multiple Myeloma
Conditions: Leukemia;   Multiple Myeloma;   Hodgkin Lymphoma;   Lymphoma, Non-Hodgkin
2 Active, not recruiting
Has Results
Campath-1H and EPOCH to Treat Non-Hodgkin's T- and NK-Cell Lymphomas
Conditions: Lymphoma, T-Cell;   Lymphoma, Extranodal NK-T-Cell
Interventions: Biological: Alemtuzumab (Campath);   Drug: EPOCH

Indicates status has not been verified in more than two years